Freshfields advised Novartis on its exclusive license agreement with Arvinas for a potential first-in-class prostate cancer treatment. Novartis, a global healthcare company, has entered into an...
Novartis’ Licensing Agreement with Arvinas
Cinven’s Acquisition of MBCC Group’s Admixtures Business
Freshfields Bruckhaus Deringer advised Cinven on the deal. Cinven Funds agreed to acquire MBCC Admixtures, a leading global manufacturer of concrete admixtures and sustainable solutions for the...
Solvay Specialty Polymers USA, LLC’s Joint Venture With Orbia Group
Freshfields Bruckhaus Deringer advised Solvay Specialty Polymers USA, LLC, while White & Case advised Orbia. Solvay Specialty Polymers USA, LLC (“Solvay”) agreed for its joint venture...
AmerisourceBergen’s $1,3 Billion Acquisition of PharmaLex
Noerr advised AUCTUS, while Freshfields Bruckhaus Deringer advised AmerisourceBergen Corporation. McDermott Will & Emery, Buntscheck and Emnay advised Auctus Capital Partners/Pharmalex. AmerisourceBergen Corporation (NYSE: ABC) signed a...